Publications

Search

Categories

September 8, 2026

| Poster

Vincent Cottin, Sanjeev Khindri, Savan Patel, Renee Jones, Rajeev Saggar

Re-Spire: A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Pulmonary Hypertension With Interstitial Lung Disease (PH-ILD) Participants

Barcelona

September 7, 2026

| Poster

Nicholas Kolaitis, Rajan Saggar, Fereidoun Abtin, Richard Channick, Savan Patel, Ashley Galloway, Rajeev Saggar

Hearing from Patients: Self-Reported Cough Outcomes During Treatment with YUTREPIA® (treprostinil) in the ASCENT Trial

Barcelona

June 12, 2026

| Poster

Seth Hall, MBA, RRT, RRT-ACCS, RRT-NPS

The Invisible Burden: Mental Health Challenges Facing Caregivers of Patients with Pulmonary Hypertension

Dallas, Texas

June 12, 2026

| Poster

Diana Gritsenko, Brittany Hardek, Savan Patel, Ashley M. West

The PHriendly Neighborhood Pharmacist: Mapping the Pharmacist’s Role in Pulmonary Hypertension Care Teams

Dallas, Texas

February 23, 2026

| Publication

Hall, S.

The Essential Role of Caregivers in Pulmonary Hypertension: A Patient Advocacy Perspective on Support, Resources, and the Unique Challenges Facing Families.

Respiratory Therapy Vol 21 No. 2 Spring 2026

January 31, 2026

| Poster

D. Lachant, A. Galloway, D. Fleming, R. Saggar, S. Patel, R. James White

Changes in Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights from the ASCENT Trial

Dublin, Ireland

January 30, 2026

| Poster

R. Restrepo-Jaramillo, A. Muralidhar, M. Trivieri, C. Burger, J. Elwing, J. Feldman, S. Shapiro, J. Yau, P. Kan, A. Leblond, S. Khindri, R. Saggar

Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Dublin, Ireland

January 29, 2026

| Poster

R. Saggar, A. Ravichandran, N. Kolaitis, A. Muralidhar, J. Feldman, M. Patricia George, R. Restrepo-Jaramillo, J. Ryan, S. Patel, A. Galloway, R. Saggar, J. White, V. McLaughlin

Safety and Exploratory Efficacy data of LIQ861 Dry Powder Inhaled Treprostinil in PH-ILD patients: ASCENT to Week 24

Dublin, Ireland

October 21, 2025

| Presentation

Lachant, D., DO

Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights from the ASCENT Trial. CHEST Annual Meeting.

Chicago, IL

October 21, 2025

| Presentation

Kolaitis, N. A.

Safety and Exploratory Efficacy Data of LIQ861 DPI Treprostinil in PH-ILD: ASCENT to Week 16. CHEST Annual Meeting

Chicago, IL

Current page 1
Page 2
Page 3
…
Next page
Last page

Pioneers in rare cardiopulmonary disease

Search